The Glimpse Group, Inc.
9DR.SG News Today: Stay Updated with the Latest The Glimpse Group, Inc. News in Real Time
Find 9DR.SG news now at Meyka AI. Stay informed with the latest The Glimpse Group, Inc. stocks updates, including price news, market analysis, and expert insights.
CHF 2.05 intraday for SDOT.SW AMINA Polkadot ETP (SIX) 31 Mar 2026: potential oversold bounce
SDOT.SW stock trades at CHF 2.05 intraday on 31 Mar 2026; analysis flags a short-term oversold bounce vs medium-term downside
United Energy (0467.HK) down 8.33% after earnings 31 Mar 2026: HKD 0.90 target
0467.HK stock falls to HKD 0.55 after results on 31 Mar 2026. Meyka AI forecast shows near-term upside to HKD 0.79–0.83.
Mibelle March 31: CEO Exit Deepens Post-Persán Turmoil, Asset Sale Talk
Mibelle faces added strain as the CEO exits by 31 March after earlier departures, while a Biochemistry sale is discussed. What CH investors should watch and why it matters.
March 31: New Caledonia Reopens 2002 Tourist Murder; Tourism Risk Watch
Swiss investors track the New Caledonia murder case rere as prosecutors reopen a 2002 file. We assess Isle of Pines security, Mika Kusama case context, and Pacific tourism impact for CH travel demand,
51.65% surge for 9159.T W TOKYO (JPX) to JPY 2,349.00 on 31 Mar 2026: watch 3,260
9159.T stock jumps 51.65% to JPY 2,349.00 on 31 Mar 2026; volume, valuation and Meyka forecast in review
ROK stock down 0.85% pre-market NYSE $348.51: AI demand supports upside
Pre-market ROK stock analysis: $348.51, PE 39.81, Meyka AI forecast $362.53 on 31 Mar 2026
Volume spike lifts 3322.T Alpha Group Inc. (JPX) to JPY 891 on 31 Mar 2026: watch price targets
3322.T stock saw a volume spike to 3,300 shares at JPY 891 on 31 Mar 2026. Quick valuation and Meyka AI forecast included.
Butong Group (6090.HK) HKSE after hours: -36.89% to HK$39.98, watch liquidity
6090.HK stock tumbles 36.89% after hours to HK$39.98 on heavy volume; valuation and technicals raise liquidity concerns
BNTX Stock Today: March 31: ELCC Cancer Data Steady Amid Biotech Rout
BioNTech stock holds near $85 as biotech volatility hits peers. ELCC cancer data on gotistobart showed 54% lower death risk in advanced lung cancer, supporting medium-term catalysts for German traders